Insiders Prime Medicine, Inc.

Equities

Market Closed - Nasdaq Other stock markets 06:00:00 13/05/26 am AEST			5-day change	1st Jan Change
3.300 ^USD	+1.85%		-2.65%	-4.90%

08/05	Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
17/04	Prime Medicine, Inc. Appoints Svetlana Makhni as Chief Financial Officer	CI

16/04	Prime Medicine, Inc. Announces Executive Changes, Effective April 16, 2026	CI
04/11	Prime Medicine, Inc. Appoints Matthew Hawryluk as Chief Business Officer	CI
16/07/25	Prime Medicine, Inc. Announces Step Down of Jeremy Duffield as Chief Scientific Officer, Effective July 15, 2025	CI
19/05/25	Prime Medicine to Cut Costs, Focus on Liver Treatment Programs; New CEO Named	MT
19/05/25	Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition	RE
19/05/25	Prime Medicine, Inc. Announces CEO Changes	CI
19/05/25	Prime Medicine, Inc. Announces Board Changes	CI
06/01/24	Prime Medicine Names Foghorn Therapeutics' CFO to be its New Finance Chief	MT
06/01/24	Prime Medicine, Inc. Announces Executive Changes, Effective January 17, 2024	CI
03/06/23	Insider Sell: Prime Medicine	MT
11/05/23	Prime Medicine, Inc. Appoints Jeff Marrazzo to Its Board of Directors	CI
27/10/22	Insider Buy: Prime Medicine	MT
27/10/22	Insider Buy: Prime Medicine	MT